30 phenotypes from 4 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Entpd1tm1a(EUCOMM)Wtsi/Entpd1tm1a(EUCOMM)Wtsi C57BL/6N-Entpd1tm1a(EUCOMM)Wtsi/Ieg	abnormal coping response	J:165965
	abnormal eye morphology	J:165965
	abnormal glucose homeostasis	J:165965
	decreased circulating glycerol level	J:165965
	increased T cell number	J:165965
	tremors	J:165965
Entpd1tm1b(EUCOMM)Wtsi/Entpd1+ C57BL/6N-Entpd1tm1b(EUCOMM)Wtsi/Ieg	increased circulating chloride level	J:211773
	increased circulating sodium level	J:211773
Entpd1tm1Djp/Entpd1tm1Djp B6.129-Entpd1tm1Djp	abnormal muscle electrophysiology	J:143010
	abnormal neurotransmitter secretion	J:143010
	abnormal synaptic norepinephrine release	J:143010
	decreased platelet aggregation	J:143010
	impaired smooth muscle contractility	J:143010
	increased neurotransmitter release	J:143010
Entpd1tm1Djp/Entpd1tm1Djp involves: 129 * C57BL/6	abnormal platelet physiology	J:76092
	normal hematopoietic system phenotype	J:76092
	normal homeostasis/metabolism phenotype	J:76092
	increased cerebral infarct size	J:76092
	increased susceptibility to ischemic brain injury	J:76092
Entpd1tm1Rdr/Entpd1tm1Rdr involves: 129S2/SvPas	abnormal blood flow velocity	J:57505
	abnormal brain morphology	J:57505
	abnormal neutrophil physiology	J:129091
	abnormal vascular endothelial cell physiology	J:57505
	cardiac fibrosis	J:57505
	decreased platelet aggregation	J:57505
	increased bleeding time	J:57505
	liver fibrosis	J:57505
	pulmonary fibrosis	J:57505
	renal fibrosis	J:57505
	spleen fibrosis	J:57505
	thrombocytopenia	J:57505